Jardiance television commercial 2022

What the Jardiance TV commercial - On It is about.

Jardiance is a medication that is used to help manage blood sugar levels in people with type 2 diabetes. As a result of the medication's effectiveness, it has gained a lot of popularity in recent years. The Jardiance marketing team has done a great job of promoting the medication, and their latest TV spot, 'On It', is a shining example of their ability to create impactful ads.

The commercial opens with a man sitting at a table in his kitchen, and he's having a conversation with his wife on the phone. She tells him that he needs to take his diabetes medication and gives him a little bit of a hard time about it. We then see the man take his medication and the camera zooms in on the pill bottle. We can see clearly that it is Jardiance.

The scene then changes to the man on a walk with his dog. He's feeling good, and he's telling his dog about all the things he's been able to do since he started taking Jardiance. He talks about how he's been able to lower his A1C, and as a result, he's been able to cut back on insulin. The man also shares that he's lost some weight and that he feels like he's in better shape than he's been in a while.

The commercial ends with the man and his dog walking away into the sunset. The voice-over makes a statement about how Jardiance is helping people with type 2 diabetes get 'On It.' It's clear from the commercial that Jardiance is making a substantial difference in the man's life, and that's precisely what the medication is designed to do.

Overall, the Jardiance TV spot 'On It' does an excellent job of showcasing the benefits of this medication for people with diabetes. It's not only making managing their disease more comfortable but also improving their overall quality of life. The use of the man and his dog helps to create a personal connection to the audience and makes the commercial engaging and effective.

Jardiance TV commercial - On It produced for Jardiance was first shown on television on September 26, 2022.